Veterinary Medical Device Regulation: How FDA Oversees Animal Equipment
FDA does not require pre-market approval for veterinary medical devices. What that means for equipment buyers, how it differs from human device regulation, and what to verify before purchasing.
If you have ever purchased a digital radiography system, an ultrasound unit, an in-house chemistry analyzer, or a CO2 surgical laser for your practice, you may have assumed it went through some form of FDA clearance — the way a human medical device would. It almost certainly did not. The FDA does not require pre-market approval for devices intended for animal use. That single fact shapes the entire equipment landscape in veterinary medicine, and most practice owners are not aware of it.
This article explains how veterinary medical devices are regulated, how that differs from the human device pathway, and what it means for equipment purchasing decisions.
The short answer
The FDA has regulatory oversight over devices intended for animal use, but it does not require submission of a 510(k), premarket approval (PMA), or any other pre-market application for veterinary devices. Manufacturers of animal-only devices are not required to register their establishments with FDA, and they are exempt from post-market reporting requirements. The manufacturer is responsible for ensuring the device is safe, effective, and properly labeled — but the enforcement mechanism is reactive, not proactive. FDA can act if a veterinary device is misbranded or adulterated, but the agency does not review it before it reaches the market.
How FDA defines a medical device
The Federal Food, Drug, and Cosmetic Act defines a medical device as "an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article" that is "intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals."
The key distinction between a drug and a device is the mechanism of action. If a product relies on chemical action in or on the body, or requires metabolism to achieve its primary effect, it is a drug. If it achieves its effect through physical or mechanical means, it is a device. Needles, syringes, surgical instruments, X-ray equipment, dental units, diagnostic test kits, and surgical lasers are devices. Antibiotics, anesthetics, and insulin are drugs.
This definition applies to both human and veterinary devices. But the regulatory requirements diverge significantly depending on whether the device is intended for human or animal use.
Human vs. veterinary device regulation: the key differences
| Regulatory requirement | Human medical device | Veterinary medical device |
|---|---|---|
| Pre-market approval (510(k), PMA, De Novo) | Required for most devices | Not required |
| Establishment registration with FDA | Required | Not required (animal-only manufacturers) |
| Device listing with FDA | Required | Not required |
| Post-market reporting (MDR) | Required (deaths, serious injuries, malfunctions) | Not required |
| Quality System Regulation (QMSR/ISO 13485) | Required (effective Feb 2, 2026) | Not required by FDA |
| Labeling review | FDA reviews as part of pre-market submission | No FDA review; manufacturer responsibility |
| Import screening (ACE/OASIS) | Full data elements required | Proposed rule pending since 2020 |
What this means in practice
For a human medical device, the manufacturer must classify the device (Class I, II, or III), submit evidence of substantial equivalence or safety and effectiveness, comply with design controls and quality management systems, and report adverse events. The FDA's Center for Devices and Radiological Health (CDRH) reviews the submission before the device can be legally marketed.
For a veterinary medical device, none of those steps are required. The manufacturer determines whether the product is safe, effective, and properly labeled. FDA's Center for Veterinary Medicine (CVM) has regulatory authority but exercises it primarily through post-market enforcement — investigating complaints, issuing warning letters, and taking action against misbranded or adulterated devices.
The gray areas
Several categories create regulatory ambiguity that practice owners should understand:
Human devices used off-label in animals
Veterinarians can legally use a human-approved medical device in an animal. Section 1006 of the FD&C Act states that nothing in the act limits a healthcare practitioner's authority to use a legally marketed device for any condition within a legitimate practitioner-patient relationship. A veterinarian using a human surgical instrument, a human ultrasound probe, or a human blood pressure monitor on a veterinary patient is acting within the law.
However, FDA encourages veterinarians to consider off-label use carefully, especially if the use is specifically contraindicated by the device's human labeling. CVM also notes that because FDA does not approve animal medical devices, the labeling on a veterinary device "may not be as well-developed as approved animal drug labeling."
Products that blur the drug/device boundary
Some products are difficult to classify. A diagnostic test kit that uses chemical reagents to detect an analyte in blood is technically a device — but if it incorporates a drug substance or makes claims about treating disease, it could fall under drug regulations. Similarly, a topical product that combines a physical barrier with a chemical active ingredient may straddle the line between device (EPA or FDA) and drug (FDA CVM).
Software and AI tools
Software functions that are intended for use in diagnosis or treatment of disease in animals generally meet the statutory definition of a medical device. But because veterinary devices do not require pre-market clearance, many veterinary AI tools — including AI scribes, diagnostic decision-support software, and image analysis algorithms — operate in a regulatory space with no FDA pre-review. This is an area of active policy discussion, and CVM's September 2023 Animal and Veterinary Innovation Agenda signaled the agency's intent to develop risk-based approaches to regulating modern veterinary products, including digital health tools.
What the proposed import rule would change
In 2020, FDA published a proposed rule that would add veterinary medical devices to the list of imported FDA-regulated products requiring data submission at the time of U.S. Customs entry through the Automated Commercial Environment (ACE) system. The required data elements would include the FDA country of production, the complete FDA product code, the intended use code, and the importer's contact information.
If finalized, this rule would give FDA better visibility into veterinary devices entering the U.S. market and improve its ability to make admissibility determinations. But it would not establish pre-market approval. The rule addresses import screening, not device review.
How human device regulation evolved in 2026
For context, the human medical device regulatory landscape underwent a significant change on February 2, 2026, when the FDA's Quality Management System Regulation (QMSR) took effect. The QMSR amended the device current good manufacturing practice requirements of 21 CFR Part 820 and incorporated by reference ISO 13485:2016 — the international standard for medical device quality management systems. After February 2, 2026, FDA device inspections shifted from the Quality System Inspection Technique (QSIT) to the updated Compliance Program 7382.850.
These requirements apply to human medical devices, not veterinary devices. But they are relevant to veterinary practice in one important way: many veterinary devices are manufactured by companies that also produce human medical devices, or they share components, manufacturing processes, or quality standards with human-labeled products. A veterinary digital radiography system built by a company that also manufactures human imaging equipment may be produced under ISO 13485 quality systems even though FDA does not require it for the veterinary version.
For a detailed breakdown of how human medical devices are classified, cleared, and approved across different regulatory jurisdictions, MedDeviceGuide covers global medical device registration pathways including the FDA 510(k) and PMA processes, EU MDR requirements, and country-specific device approval strategies.
What practice owners should verify before purchasing
Given the lack of pre-market review, the burden of due diligence falls more heavily on the veterinary equipment buyer than on the regulator. Here is what to check:
1. Manufacturer reputation and track record
How long has the manufacturer been making veterinary equipment? Do they have a history of product recalls, warning letters, or complaint patterns? Check the FDA's enforcement reports and the Manufacturer and User Facility Device Experience (MAUDE) database — although the MAUDE database covers human devices, manufacturers who also make human devices will appear there.
2. Whether the device has human-market clearance
If the device is a human-cleared medical device being marketed for veterinary use, it has gone through at least the 510(k) process. This does not guarantee safety or effectiveness in animals, but it means the device met manufacturing and labeling standards for the human market. Ask the manufacturer whether the device is the same model as a human-cleared version.
3. Clinical validation data specific to veterinary use
Has the manufacturer conducted or sponsored any studies evaluating the device's performance in the target veterinary species? A CO2 laser used for feline onychectomy, a digital radiography system calibrated for small-animal thoracic imaging, or an in-house analyzer validated against reference laboratory methods for canine and feline samples — these are the types of veterinary-specific evidence that distinguish a purpose-built veterinary device from a relabeled human product.
4. Service and support infrastructure
Without post-market reporting requirements, there is no regulatory mechanism to flag device failures. Ask about warranty terms, service response times, availability of loaner equipment, and the manufacturer's track record for firmware updates and technical support.
5. Labeling accuracy
Because FDA does not review veterinary device labeling before market entry, verify that the manufacturer's claims match the available evidence. Be skeptical of claims that go beyond what clinical validation supports — particularly for diagnostic accuracy, measurement precision, or treatment outcomes.
Reporting problems with veterinary devices
FDA encourages veterinarians and consumers to report problems with animal devices. Although post-market reporting is not required for manufacturers of animal-only devices, CVM can and does take enforcement action when devices are found to be misbranded or adulterated. Reports can be submitted through the FDA's Safety Reporting Portal.
CVM also shares human medical device recall announcements that may affect veterinary settings, since many veterinary practices use human-approved devices off-label.
The regulatory landscape is evolving
CVM's 2023 Animal and Veterinary Innovation Agenda identified four objectives for modernizing the regulation of animal and veterinary products, including increased regulatory flexibility, predictability, and efficiency. The agenda specifically addresses digital health tools, AI-based diagnostics, and other emerging technologies that blur traditional product category boundaries.
For now, the regulatory framework for veterinary medical devices remains substantially less rigorous than for human devices. This creates both opportunities — faster market entry for innovative veterinary equipment — and risks — less pre-market scrutiny of safety and effectiveness claims. Practice owners who understand the difference can make more informed equipment decisions.
Sources
- FDA. "How FDA Regulates Animal Devices." U.S. Food and Drug Administration. https://www.fda.gov/animal-veterinary/animal-health-literacy/how-fda-regulates-animal-devices
- FDA. "Animal Medical Devices." U.S. Food and Drug Administration. https://www.fda.gov/animal-veterinary/products/animal-medical-devices
- FDA. "Overview of Device Regulation." U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/overview-device-regulation
- FDA. "Development & Approval Process — Animal Drugs." U.S. Food and Drug Administration. https://www.fda.gov/animal-veterinary/development-approval-process
- Covington & Burling LLP. "FDA Announces Proposed Rule to Require Veterinary Device Submissions to CBP's Automated Commercial Environment." https://www.cov.com/en/news-and-insights/insights/2020/08/fda-announces-proposed-rule-to-require-veterinary-device-submissions-to-customs-and-border-protections-automated-commercial-environment
- Hogan Lovells. "FDA Device Guidance Agenda: What to Watch in 2026." https://www.hoganlovells.com/en/publications/fda-device-guidance-agenda-what-to-watch-in-2026
- Animal Health Consulting. "Veterinary Regulations — FDA-CVM, USDA-CVB." https://animalhealthconsulting.com/veterinary-regulations
- Morgan Lewis. "Innovation at the FDA: Efforts to Decrease Animal Testing and Usher in New Technologies." https://www.morganlewis.com/pubs/2026/03/innovation-at-the-fda-efforts-to-decrease-animal-testing-and-usher-in-new-technologies
- Congressional Research Service. "FDA Regulation of Medical Devices." https://www.congress.gov/crs-product/R47374
